Editor-in-Chief Of ESMO Rare Cancers, a New, Online, Open Access Journal from ESMO
ESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe.
ESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe.
The world’s most influential people in health have made fresh discoveries, dreamed up novel treatments, and pioneered global victories over disease.
Stay ahead in precision medicine with the 2nd Biennial Miami Precision Medicine conference. Join healthcare professionals for cutting-edge CME events, featuring expert insights, innovative strategies,…
A highly pathogenic avian influenza A(H5N1) virus infection was identified in a dairy farm worker in Texas. This pathogen has been reported in multiple dairy…
The presence of BRAF mutation in hematological malignancies, excluding Hairy cell leukemia, and its significance as a driver mutation in myeloid neoplasms (MNs) remains largely…
This cohort study evaluates tumor mutational burden and outcomes in patients with diverse advanced cancers treated with immunotherapy.
Background Tumor mutational burden (TMB), defined as the number of somatic mutations per megabase of a tumor, is routinely used as a predictive biomarker for…
Clinical Pharmacology & Therapeutics is a cross-disciplinary clinical medicine journal publishing advances in the nature, action, efficacy, and evaluation of therapeutics.
Background: Patients with cancer of unknown primary (CUP) have a poor prognosis due to delays in diagnostic workup and empirically-selected platinum-based regimens that may not…
3077 Background: While targeted DNA-seq can detect clinically actionable fusions in tumor tissue samples, technical and analytical challenges may give rise to false negatives. RNA-based,…
3017 Background: Next generation sequencing (NGS) of tumor tissue and plasma (circulating tumor DNA [ctDNA]) are used clinically to identify actionable genomic alterations, with implications…